December 16, 2020
In re Xyrem (Sodium Oxybate) Antitrust Litigation
Case Number:
3:20-md-02966
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
15:15 Antitrust Litigation
Judge:
Firms
- Barnes & Thornburg
- Benesch
- Berger Montague
- Boies Schiller
- DiCello Levitt
- Faegre Drinker
- Fine Kaplan
- Frost Brown
- Gibson Dunn
- Girard Sharp
- Goodwin Procter
- Hagens Berman
- Holland & Knight
- Husch Blackwell
- Joseph Saveri Law Firm
- Kirkland & Ellis
- Labaton Keller
- Law Offices of Robert W. Sink
- Lowey Dannenberg
- Motley Rice
- O'Melveny & Myers
- Radice Law Firm
- Rawlings & Associates PLLC
- Salahi PC
- Schneider Wallace
- Schneider Wallace Cottrell Konecky LLP
- Scott&Scott
- Skaggs Faucette
- Spector Roseman
- Spiro Harrison
- Steven Williams Law
- Troutman
- Weil Gotshal
- Wexler Boley
- White & Case
- Williams & Connolly
- Wilson Sonsini
- Winston & Strawn
- Zelle LLP
- Zimmerman Reed
Companies
- Aetna Inc.
- Amneal Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Endo International PLC
- Express Scripts Holding Co.
- Florida Blue
- Government Employees Health Association Inc.
- Health Care Service Corp.
- Hikma Pharmaceuticals PLC
- Humana Inc.
- Jazz Pharmaceuticals Inc.
- Lupin Ltd.
- Mallinckrodt PLC
- Molina Healthcare Inc.
- Par Pharmaceutical Cos. Inc.
- Ranbaxy
- Teva Pharmaceutical Industries Ltd.
- United Food & Commercial Workers International Union
- Veranova LP
- West-Ward Pharmaceutical Corp.
- Wockhardt USA LLC
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 08, 2025
Jazz Agrees To Pay $145M To Settle Xyrem Antitrust Fight
Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation accusing it of working with its rival Hikma Pharmaceuticals to stave off generic competitors to Jazz's narcolepsy drug Xyrem, the Ireland-based pharmaceutical company revealed Tuesday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login